One step further in targeting acute leukemia by combining antibody-based immunotherapies and small molecule inhibitors

Abstract Background Acute leukemia is a bone marrow-related disease characterized by fast progression and the production of immature blood cells rather than normal ones that are classified as either acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). Chemotherapy as a conventional tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Armin Dozandeh-Jouybari, Erfan Rohaninia, Sara Faaliat, Nazanin Joudaki, Sara Ghandi, Maryam Talebi Moghaddam, Saeid Taghiloo, Tohid Kazemi
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-025-03869-w
Tags: Add Tag
No Tags, Be the first to tag this record!